Meros Pharm
Meros Pharm is a private wholesale pharmaceutical distributor in Uzbekistan operating seven GDP-certified warehouses and a 129-vehicle fleet to distribute 8,000+ products from 400+ manufacturers to 7,000+ pharmacy customers, holding the #1 market position since 2016.
- Company typePrivate
- Founded2007
- HeadquartersSamarkand, Uzbekistan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Meros Pharm does
Meros Pharm is a private wholesale pharmaceutical distributor headquartered in Samarkand, Uzbekistan, founded in 2007. The company operates seven GDP-certified warehouses totaling 28,000+ square meters across all seven economic regions of Uzbekistan and runs an owned fleet of 129 temperature-controlled vehicles, giving it nationwide last-mile reach to 7,000+ retail pharmacy customers. Its portfolio includes 8,000+ drug names sourced from 400+ international manufacturers, with 500+ exclusive distribution rights covering products from AstraZeneca, Sanofi-Aventis, Novartis, KRKA, Dr. Reddy's, Polpharma, Grindex, and Olainfarm.
The company generates revenue primarily through wholesale markup on distributed pharmaceutical products, billed on a transactional B2B basis to pharmacies and pharmacy chains, with a secondary revenue stream from temperature-controlled logistics and warehousing services. Its go-to-market combines direct enterprise field sales to pharmacy chains (including Olam Pharm, City Pharm, and the company-owned MEROS chain of 150 outlets) with self-serve ordering via a mobile application on Google Play and App Store. Operationally, internal TMS and WMS systems manage transport corridors and warehouse workflows to GDP standards, and a recently launched MEROS Academy delivers workforce training in partnership with UK-based People 1st and Skills for Logistics.
Meros has held the #1 position in Uzbekistan's pharmaceutical distribution market since 2016 and over 25% market share since 2022. Growth has been financed primarily through three debt facilities from the European Bank for Reconstruction and Development (EBRD) — $23 million in 2023, $15 million in mid-2025 for new warehouse construction, and $25 million in late 2025 — with technical assistance from the Japan-EBRD Cooperation Fund. The company remains founder-led under Komilov Nasimjon, who was awarded the state 'Shuhrat' medal in August 2025.
Meros Pharm firmographics
Firmographics- Name
- Meros Pharm
- Legal name
- Meros Pharm MCHJ
- Website
- https://merospharm.uz
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Meros Pharm is a private wholesale pharmaceutical distributor in Uzbekistan operating seven GDP-certified warehouses and a 129-vehicle fleet to distribute 8,000+ products from 400+ manufacturers to 7,000+ pharmacy customers, holding the #1 market position since 2016.
- Ownership category
- akta.pro rank
Meros Pharm industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Full-Line Pharmaceutical Wholesalers (HLAIAJAA)
- akta.pro secondary industries
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Retail Pharmacy Supply Wholesalers (HLAIAJAE), Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)
Keywords
Where Meros Pharm is headquartered
LocationHeadquarters
- HQ city
- Samarkand
- HQ country
- Uzbekistan
- HQ region
- Asia
Offices8 records
Markets served
Meros Pharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Pharmaceutical Wholesale Distribution: Wholesale distribution of pharmaceutical products to pharmacies and pharmacy chains across Uzbekistan. Revenue generated through markup on pharmaceutical products sourced from international manufacturers and distributed to retail pharmacy customers. Portfolio includes 7,000+ products with 500+ exclusive pharmaceutical products.
- Logistics and Distribution Services: Temperature-controlled pharmaceutical logistics and distribution services using own fleet of 129 vehicles. Revenue from providing warehousing and last-mile delivery services to pharmacy customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Wholesale B2B pricing for pharmacies and pharmacy chains |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Meros Pharm product offering
Product offeringCore offering
Meros Pharm is a wholesale pharmaceutical distributor that sources medicines from 400+ international manufacturers and distributes them to 7,000+ pharmacy customers across Uzbekistan. The company operates seven GDP-certified warehouses spanning 28,000+ square meters and a 129-vehicle cold chain delivery fleet, supplemented by a pharmacy-facing mobile ordering app and an in-house pharmacy retail chain.
Product overview
Meros Pharm operates as a single unified pharmaceutical wholesale distribution platform. The core offering is pharmaceutical distribution services, supported by GDP-certified warehouse storage and cold chain logistics operations. The company manages internal TMS and WMS systems for operational efficiency. The product portfolio includes the mobile application for client ordering, the MEROS Academy for employee training, and the MEROS pharmacy chain for retail operations. All offerings are interconnected within the distribution value chain: manufacturers supply products → warehouses store under GDP standards → TMS manages transport logistics → mobile app enables ordering → pharmacies receive delivery.
Differentiator
Problem solved
Functional benefit
Brands
- Meros Academy: Corporate university for employee training and professional development, established with support from EBRD and international partners including People 1st and Skills for Logistics.
Products and services
- Pharmaceutical Wholesale Distribution Full-spectrum wholesale distribution of pharmaceutical products from 400+ international manufacturers to 7,000+ regular pharmacy customers across Uzbekistan, including 500+ exclusive drugs from a portfolio of 8,000+ SKUs. Targeted at retail pharmacies and pharmacy chains.
- GDP-Certified Warehouse Storage Pharmaceutical-grade storage services through seven GDP (Good Distribution Practice) certified warehouses totaling 28,000+ square meters across Uzbekistan's seven regions. Designed for pharmaceutical manufacturers and pharmacy customers requiring compliant storage.
- Cold Chain Pharmaceutical Logistics Temperature-controlled transportation of pharmaceutical products using refrigeration-equipped vehicles, managed through a TMS (Transport Management System). Available to pharmacy customers across Uzbekistan for last-mile and regional delivery.
- Meros Pharm Mobile Application Mobile app for pharmacy customers to browse the pharmaceutical catalog and place orders. Available on Google Play and App Store.
- MEROS Pharmacy Chain Retail pharmacy chain of 150 company-owned outlets across Uzbekistan, including the Olam Pharm and City Pharm brands. Serves end consumers with pharmaceutical products sourced through Meros Pharm's distribution network.
- MEROS Academy Corporate training and professional development program for Meros Pharm employees and partners, delivered in partnership with EBRD, People 1st (UK), and Skills for Logistics (UK). Includes warehouse management training in a 50-seat training center in Samarkand.
Quantifiable outcome
- 25%+ market share in Uzbekistan pharmaceutical distribution since 2022
- +2 more outcomes
Companies that use Meros Pharm
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Meros Pharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Meros Pharm partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered major and core.
- Samarqand Davlat Tibbiyot Universiteti (Samarkand State Medical University)majorMemorandum of cooperation signed for student development. Implemented 'Meros Pharm' Scholarship program for talented students in medical and pharmaceutical fields. Aims to support talented and ambitious students financially and professionally.
- Zarmed UniversitetimajorPartnership memorandum for joint projects including grant-funded initiatives, workforce qualification improvement, scientific research, and educational services. Based on principles of mutual respect and trust.
- People 1st (UK)majorInternational training and workforce development company partnering with Meros Academy for trainer development programs, warehouse management training, and skills development initiatives. Collaboration includes custom program development and trainer certification.
- Skills for Logistics (UK)majorPartnership with Meros Academy for warehouse management training programs delivered in a 50-seat training center in Samarkand. Focus on logistics and quality systems management skills.
- British Medical Education DelegationmajorPartnership for creating an innovative center for medical education. Delegation included UK experts in medical education and training. Discussed cooperation, training nurses according to international standards, and implementation of British approaches in educational system.
- AstraZeneca ABcoreExclusive distribution partnership for AstraZeneca products in Uzbekistan including Betaloc ZOC, Nexium, Pulmicort, Symbicort, Forxiga, and other pharmaceutical products.
- KRKAcoreMajor pharmaceutical manufacturer with 104 products distributed by Meros Pharm including Enap, Lorista, Valsacor, Rokser, Aторис, and other cardiovascular and general medicine products.
- Dr. Reddy'scoreIndian pharmaceutical company with 44 products distributed including Omez, Nakom, Naise, Momaт, Tелсартан, and other medications.
- Sanofi-AventiscoreMajor global pharmaceutical company with products including Clexane, Lantus, Soliqua, and other specialty medications distributed in Uzbekistan.
- Novartis Pharma AGcoreProducts distributed include Visqy for ophthalmic applications and Skaflo powder. Major global pharmaceutical manufacturer.
- Polfarma (Польфарма)corePolish pharmaceutical company with 36 products including Aquadetrim, Biseptol, Trokhopol, and other medications distributed in Uzbekistan.
- Grindex (Гриндекс)coreLatvian pharmaceutical company with products including Mildronate, Betamax, Karmend, Venlaksor, and other cardiovascular and neurological medications.
- OlainfarmcoreLatvian pharmaceutical company with products including Noofen, Fenkarol, Furamag, Adaptol, Neuromidin, Etacizin and other neurological and general medications.
- Olam PharmmajorMajor Uzbek pharmacy chain - one of the key distribution customers. Part of 150 pharmacy network in Uzbekistan served by Meros Pharm.
- City PharmmajorMajor Uzbek pharmacy chain - key distribution customer. Part of 150 pharmacy network in Uzbekistan served by Meros Pharm.
- MEROS pharmacy chainmajorCompany-owned pharmacy chain with 150 pharmacies across all regions of Uzbekistan, representing 8 years of work in the pharmaceutical retail market.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Meros Pharm competitors and assessment
Company assessmentDirect peers
- Remedium: Russian pharmaceutical distributor with Central Asian reach, focused on wholesale supply to retail pharmacies. Closely matches Meros's core activity of multi-manufacturer wholesale distribution with regional logistics coverage.
- Katren: One of Russia's largest pharmaceutical distributors with regional CIS operations, including Central Asia. Directly comparable as a wholesale pharmaceutical distributor serving retail pharmacy chains with GDP-equivalent warehousing and a national fleet — same business model and customer profile as Meros.
- Pulse Pharma: Uzbekistan-based pharmaceutical distributor operating in the same domestic market. Directly competes with Meros for the same pool of pharmacy customers and international supplier exclusive-distribution contracts.
Broad incumbents
- Cardinal Health: Major global pharmaceutical distributor operating across the US, Canada, and Europe. Relevant as a benchmark for distribution economics and as a potential future competitor or partner for cross-border pharma distribution into Uzbekistan.
- Pharmstandard: Largest Russian pharmaceutical manufacturer and distributor with significant CIS and Uzbekistan presence. Comparable as a CIS-focused pharmaceutical wholesaler serving retail pharmacies, but with a much broader manufacturing-plus-distribution portfolio than Meros's pure-play distribution model.
- Alliance Healthcare (Walgreens Boots Alliance): Global pharmaceutical wholesaler and pre-wholesaler serving retail pharmacies and pharmacists across Europe. Comparable as an established broad-line pharma distributor; represents the type of global incumbent Meros could compete against as Uzbekistan's market opens.
- McKesson: Largest global pharmaceutical distributor and healthcare services company. While not directly active in Uzbekistan, it represents the international scale benchmark for wholesale pharma distribution and a potential entrant or partner as Central Asian markets liberalize.
- AmerisourceBergen (Cencora): Top-tier global pharmaceutical wholesaler serving pharmacies, hospitals, and manufacturers worldwide. Comparable as a broad-line distributor with manufacturer-partner programs analogous to Meros's exclusive AstraZeneca/Novartis/Sanofi deals.
Regional players
- Apteka.uz: Uzbekistan's leading online pharmacy aggregator and retail platform. Adjacent peer operating at the retail pharmacy layer that Meros serves as a wholesaler; both shape demand for pharmaceutical products in the Uzbek market.
Others
- Olam Pharm: One of Meros's largest pharmacy chain customers in Uzbekistan (150+ pharmacies). Although primarily a customer, vertically integrated pharmacy chains are a structural alternative to third-party wholesale distribution in Uzbekistan and could become a competitor if they internalize procurement.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Meros Pharm compliance and trust
Trust signalCompliance3 records
Meros Pharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Meros Pharm leadership team
Management profileNumber of profiles
Profiles2 records
Meros Pharm funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Meros Pharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Meros Pharm
What does Meros Pharm do?
Meros Pharm is a wholesale pharmaceutical distributor that sources medicines from 400+ international manufacturers and distributes them to 7,000+ pharmacy customers across Uzbekistan. The company operates seven GDP-certified warehouses spanning 28,000+ square meters and a 129-vehicle cold chain delivery fleet, supplemented by a pharmacy-facing mobile ordering app and an in-house pharmacy retail chain.
Is Meros Pharm a public or private company?
Meros Pharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Meros Pharm founded?
Meros Pharm was founded in 2007. It employs 1,001 to 5,000 people.
Where is Meros Pharm based?
Meros Pharm is headquartered in Samarkand, Uzbekistan, in the Asia region.
How does Meros Pharm make money?
Two revenue lines are on record. Pharmaceutical Wholesale Distribution is the primary driver. The others are logistics and Distribution Services.
Who are Meros Pharm's main competitors?
Direct peers on record are Remedium, Katren and Pulse Pharma. Broad incumbents are Cardinal Health, Pharmstandard, Alliance Healthcare (Walgreens Boots Alliance), McKesson and AmerisourceBergen (Cencora). Apteka.uz is listed as a regional player. Olam Pharm is listed as an others.
Does Meros Pharm have an API?
No public API is recorded for Meros Pharm.
What industry is Meros Pharm in?
Meros Pharm's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAA, Full-Line Pharmaceutical Wholesalers, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5047.